Dermatologicals in Portugal

 Published On: Sep, 2016 |    No of Pages: 29 |  Published By: Euromonitor | Format: PDF
The performance of dermatologicals in 2016, which saw current value sales increase by 1%, was partly attributable to the categorys recovery from the declines recorded in earlier years of the review period. Also, several switches took place in 2014 and 2015, increasing the list of OTC dermatologicals and therefore boosting sales. In 2016 dermatologicals increased by 1% in current value terms, which was a better performance than the contracting CAGR of 1% seen over the review period.

Dermatologicals in Portugal report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the markets major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
DERMATOLOGICALS IN PORTUGAL

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Dermatologicals by Category: Value 2011-2016
Table 2 Sales of Dermatologicals by Category: % Value Growth 2011-2016
Table 3 NBO Company Shares of Dermatologicals: % Value 2012-2016
Table 4 LBN Brand Shares of Dermatologicals: % Value 2013-2016
Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2013-2016
Table 6 Forecast Sales of Dermatologicals by Category: Value 2016-2021
Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2016-2021
Laboratorio Medinfar Produtos Farmaceuticos SA in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 1 Laboratorio Medinfar: Key Facts
Competitive Positioning
Summary 2 Laboratorio Medinfar: Competitive Position 2016
Novartis Farma - Produtos Farmaceuticos SA in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 3 Novartis Farma - Produtos Farmaceuticos SA: Key Facts
Competitive Positioning
Summary 4 Novartis Farma - Produtos Farmaceuticos SA: Competitive Position 2016
Omega Pharma Portuguesa Unipessoal Lda in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 5 Omega Pharma Portuguesa Unipessoal Lda: Key Facts
Competitive Positioning
Summary 6 Omega Pharma Portuguesa Unipessoal Lda: Competitive Position 2016
Pfizer Sa, Laboratorios in Consumer Health (portugal)
Strategic Direction
Key Facts
Summary 7 Laboratorios Pfizer SA: Key Facts
Competitive Positioning
Summary 8 Laboratorios Pfizer SA: Competitive Position 2016
Executive Summary
Consumer Health Enjoys Positive Value Growth in 2016
Health and Wellness Remains Important in Portugal, Despite Economic Constraints
Fragmentation Characterises the Consumer Health Market in 2016
Chemists/pharmacies Account for the Majority of Sales, Followed by Supermarkets
Consumer Health Is Forecast To Register Positive Growth Between 2016 and 2021
Key Trends and Developments
Consumers Remain Fairly Cautious Despite Many Positive Economic Indicators
Ongoing Trend Towards Self-medication
Consumer Health Sales Driven by the Ageing and Obesity Trends
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format: % Value 2011-2016
Table 16 Distribution of Consumer Health by Format and Category: % Value 2016
Table 17 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 9 Research Sources
If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.